-+ 0.00%
-+ 0.00%
-+ 0.00%

The peak sales forecast for AstraZeneca Efzimfotase Alfa is expected to reach 5 billion US dollars, and executives believe this bone disease drug is expected to be approved.

Zhitongcaijing·10/11/2026 21:09:02
Listen to the news
The peak sales forecast for AstraZeneca Efzimfotase Alfa is expected to reach 5 billion US dollars, and executives believe this bone disease drug is expected to be approved.